Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Deletion of the angiopoietin receptor Tie2 enhances proliferation and sprouting of cardiac endothelial cells

Anisimov A., Lackman MH., Augustin HG., Mervaala E., Alitalo K., Karaman S.

Animal Study on Cardiovascular Disease, published in Angiogenesis (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Angiogenesis (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41563573
PMCID
PMC12823625
DOI
10.1007/s10456-025-10028-2

Abstract (original English)

Background Endothelial cells (ECs) of the heart proliferate and form new vessels in response to vascular endothelial growth factor (VEGF), but VEGF has not benefited the therapy of cardiac ischemia because of its side effects. Here, we explored if deletion of the vascular steady-state homeostasis maintaining Tie1 and Tie2 receptor tyrosine kinases affects the proliferation and sprouting of cardiac ECs. Methods We analyzed EC proliferation and histological and immunohistochemical stainings by confocal microscopy, plus scRNA and qPCR analyses of gene expression in the heart, kidneys, and lungs of Tie1 fl/fl , Tie2 fl/fl , and Tie1 fl/fl ;Tie2 fl/fl mice, in which vascular endothelial cadherin-driven CreER T2 recombinase was used to delete Tie1, Tie2 or both receptors. These analyses were also performed in mice subjected to transverse aortic constriction (TAC). Boyden chamber assays were performed to assess the migration of cultured ECs in cultures with or without TIE receptor silencing. Results Genetic deletion of Tie1, Tie2, or Tie1/Tie2 in mice increased significantly the proliferation of cardiac but not renal or pulmonary ECs, as measured by EdU incorporation into DNA and quantification of the cell cycle marker cyclin D1. Tie1/Tie2 or Tie2 deletion, but not Tie1 deletion alone, induced EC sprouting in coronary vasculature and expression of endothelial tip cell markers, includi

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
MyocardiumEndothelial CellsAnimalsMiceReceptor, TIE-1Receptor, TIE-2Cell ProliferationCell MovementGene DeletionNeovascularization, Physiologic

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research